Filtros de búsqueda

Lista de obras de

A Phase I study to assess the safety, pharmacokinetics and efficacy of barasertib (AZD1152), an Aurora B kinase inhibitor, in Japanese patients with advanced acute myeloid leukemia ⬇️

artículo científico publicado el 11 de mayo de 2011

A new diagnostic kit, ODK-1201, for the quantitation of low major BCR-ABL mRNA level in chronic myeloid leukemia: correlation of quantitation with major BCR-ABL mRNA kits

artículo científico publicado en 2015

A phase III study of the efficacy and safety of meropenem in patients with febrile neutropenia

artículo científico publicado el 1 de agosto de 2012

A specific mode of microsatellite instability is a crucial biomarker in adult T-cell leukaemia/lymphoma patients

artículo científico publicado en 2016

Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study

artículo científico publicado en 2012

Allogeneic stem cell transplantation for adult T-cell leukemia/lymphoma

artículo científico publicado en 2007

Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma

artículo científico publicado en 2005

An integrated manual for hematologists and dermatologists to access the guidelines for the management of adult T-cell leukemia-lymphoma (2014).

artículo científico publicado en 2014

Analyses of plasma thrombopoietin levels in patients with thrombocytopenia

artículo científico publicado el 1 de junio de 2012

Augmentation of donor-derived Tax-specific CTL responses by a novel Tax epitope-specific CD4+ helper T-cells in ATL patients after allogeneic hematopoietic stem cell transplantation.

artículo científico publicado en 2014

Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study

artículo científico publicado en 2015

Can allo-SCT with RIC cure ATLL? Long-term survivors with excellent PS and with heterogenous HTLV-1 proviral load level

artículo científico publicado en 2011

Cladribine monotherapy for patients with relapsed or refractory indolent non-Hodgkin lymphoma

artículo científico publicado en 2004

Clinical significance of telomerase activity in multiple myeloma

artículo científico publicado en 2002

Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study

artículo científico publicado en 2012

Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109).

artículo científico publicado en 2003

Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial

artículo científico publicado en 2015

Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study

artículo científico publicado en 2015

Efficacy and Safety of the Modified EPOCH Regimen (Etoposide, Vincristine, Doxorubicin, Carboplatin, and Prednisolone) for Adult T-cell Leukemia/Lymphoma: A Multicenter Retrospective Study

scientific article published on 20 March 2020

Efficacy of upfront high-dose chemotherapy plus rituximab followed by autologous peripheral blood stem cell transplantation for untreated high-intermediate-, and high-risk diffuse large B-cell lymphoma: a multicenter prospective phase II study (JSCT

artículo científico publicado en 2016

Epidemiological and clinical features of adult T-cell leukemia-lymphoma (ATL) in Japan, 2010-2011: a nationwide survey

artículo científico publicado en 2017

Erratum to: Japanese phase II study of rituximab maintenance for untreated indolent B-cell non-Hodgkin lymphoma with high tumor burden

artículo científico publicado en 2016

Expression of human tumor-associated antigen RCAS1 in adult T-cell leukemia/lymphoma

artículo científico publicado en 2004

Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma.

artículo científico publicado en 2015

Factors prognostic of eligibility for allogeneic HCT among older patients with AML-CR1 and adverse- or intermediate-risk cytogenetics

artículo científico publicado en 2015

Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment

artículo científico publicado en 2018

Frequent microsatellite instability in non-Hodgkin lymphomas irresponsive to chemotherapy

scientific article published on 04 January 2008

Functional impairment of Tax-specific but not CMV-specific CTLs in a minor population of asymptomatic HTLV-1-carriers

Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers ⬇️

artículo científico publicado el 7 de diciembre de 2011

Heterochronous occurrence of microsatellite instability in multiple myeloma - an implication for a role of defective DNA mismatch repair in myelomagenesis

artículo científico publicado en 2018

Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia/lymphoma

artículo científico

Identification of the human eosinophil lineage-committed progenitor: revision of phenotypic definition of the human common myeloid progenitor

artículo científico publicado en 2009

Impact of graft-versus-host disease on allogeneic hematopoietic cell transplantation for adult T cell leukemia-lymphoma focusing on preconditioning regimens: nationwide retrospective study.

artículo científico publicado en 2013

Infection control for the treatment of hematological malignancies: a survey of the Kyushu Hematology Organization for Treatment Study Group (K-HOT)

artículo científico publicado en 2003

Japanese phase II study of rituximab maintenance for untreated indolent B-cell non-Hodgkin lymphoma with high tumor burden

artículo científico publicado en 2016

Low incidences of acute and chronic graft-versus-host disease after unrelated bone marrow transplantation with low-dose anti-T lymphocyte globulin

artículo científico publicado en 2012

Melphalan-prednisolone and vincristine-doxorubicin-dexamethasone chemotherapy followed by prednisolone/interferon maintenance therapy for multiple myeloma: Japan Clinical Oncology Group Study, JCOG0112

scientific article published on 19 January 2011

Molecular characterization of chronic-type adult T-cell leukemia/lymphoma

artículo científico publicado en 2014

Monitoring minimal residual disease in patients with MLL-AF6 fusion transcript-positive acute myeloid leukemia following allogeneic bone marrow transplantation

scientific article published on 01 April 2002

Multicenter Phase II Study of Bendamustine Plus Rituximab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma ⬇️

artículo científico publicado el 6 de mayo de 2013

Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma

artículo científico publicado en 2010

Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma

artículo científico publicado en 2014

Oncogene associated cDNA microarray analysis shows PRAME gene expression is a marker for response to anthracycline containing chemotherapy in patients with diffuse large B-cell lymphoma.

artículo científico publicado en 2009

Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial

artículo científico publicado en 2018

Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma

scientific article published on 22 February 2010

Phase II study of cladribine (2-chlorodeoxyadenosine) in relapsed or refractory adult T-cell leukemia-lymphoma

artículo científico publicado en 2003

Phase II/III study of R-CHOP-21 versus R-CHOP-14 for untreated indolent B-cell non-Hodgkin's lymphoma: JCOG 0203 trial

artículo científico publicado en 2011

Potential Contribution of a Novel Tax Epitope–Specific CD4+ T Cells to Graft-versus-Tax Effect in Adult T Cell Leukemia Patients after Allogeneic Hematopoietic Stem Cell Transplantation ⬇️

artículo científico publicado el 8 de marzo de 2013

Prognosis of mature T cell lymphoma is poorer than that of diffuse large B cell lymphoma in IPI low-risk group, but not in intermediate- and high-risk groups

artículo científico publicado en 2012

Prognostic Index for Acute- and Lymphoma-Type Adult T-Cell Leukemia/Lymphoma ⬇️

artículo científico publicado el 2 de abril de 2012

Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era.

artículo científico publicado en 2009

Promising results of an anti-CCR4 antibody, KW-0761, for relapsed Adult T-Cell Leukemia-Lymphoma (ATL)

article published in 2011

Prospective studies of allogeneic hema topoietic stem cell transplantation for adult T-cell leukemia-lymphoma

artículo científico publicado en 2015

Registration of hematological disorders by the Kyushu Hematology Organization for Treatment (K-HOT) Study Group

artículo científico publicado en 2004

Remission induction therapy containing rituximab markedly improved the outcome of untreated mature B cell lymphoma

artículo científico publicado en 2008

Retrospective analysis of cord blood transplantation on 62 adult patients with advanced hematological malignancies

artículo científico publicado en 2006

Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan: a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group

artículo científico publicado en 2010

Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab: a multicenter phase II study

artículo científico publicado en 2011

The kinetics of HTLV-1 proviral load after allogeneic hematopoietic cell transplantation with reduced intensity conditioning regimen; a comparison with that from sibling donors and that from unrelated donors

artículo científico publicado en 2014

The leucine twenty homeobox (LEUTX) gene, which lacks a histone acetyltransferase domain, is fused to KAT6A in therapy-related acute myeloid leukemia with t(8;19)(p11;q13).

artículo científico publicado en 2014

The outcome and characteristics of patients with relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation

scientific article published on 28 September 2018

The phase-I study of a therapeutic vaccine to ATL patients with autologous dendritic cells pulsed with peptides corresponding to Tax-specific CTL epitopes

artículo científico publicado en 2014

Treatment and survival among 1594 patients with ATL.

artículo científico publicado en 2015

Treatment of patients with adult T cell leukemia/lymphoma with cord blood transplantation: a Japanese nationwide retrospective survey.

artículo científico publicado en 2014

Treatment of relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: the Nagasaki Transplant Group experience

artículo científico publicado en 2012

[Vitamin K2 therapy for myelodysplastic syndrome]

artículo científico publicado en 2002

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda